MedPath

The Signal-Trial: Evaluation of a screening tool for psychosocial problems in cancer genetics.

Recruiting
Conditions
Cancer geneticsPsychosocial problemsOnco-geneticaPsychosociale problemen
Registration Number
NL-OMON21151
Lead Sponsor
etherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI AVL), University Medical Center Utrecht (UMCU)
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
260
Inclusion Criteria

1. Between 18 and 70 years of age;

2. Sufficient command of the Dutch language to complete questionnaires;

Exclusion Criteria

Those who do not fulfill the inclusion criteria.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Increased communication on psychosocial issues, measured using an audiotape of the counseling session and telephone follow-up;<br /><br>2. Counselors awareness of psychosocial problems of the counselee, measured using a checklist being completed by the counselor after the counseling session and the telephone follow-up;<br /><br>3. Management of the psychosocial problems of the counselee, measured using an audiotape of the counseling session and telephone follow-up.
Secondary Outcome Measures
NameTimeMethod
1. Number of initiations of discussed problems, measured using an audiotape of the counseling session and telephone follow-up;<br /><br>2. Time spent on psychosocial problems, measured using an audiotape of the counseling session and telephone follow-up;<br /><br>3. Satisfaction of counselor and counselee, measured using self-developed questions. Measured within the questionnaire after the counseling session and the telephone follow-up;<br /><br>4. Levels of cancer worries of the counselee, assessed using the Cancer Worry Scale. Measured using the questionnaire at baseline, after the counseling session and after the telephone follow-up;<br /><br>5. Number of psychosocial problems, assessed using the Signal-checklist. Measured at the intervention timepoints, and is part of the questionnaire after the telephone follow-up;<br /><br>6. Feasability of implementing a questionnaire, assessed using self-developed questions within the questionnaire after the telephone follow-up.
© Copyright 2025. All Rights Reserved by MedPath